Craft

Janpix

Total Funding

$22 M

Janpix Summary

Company Summary

Overview
Janpix is a biotechnology company discovering and developing inhibitors to help patients suffering from cancer. It provides a pipeline of STAT (signal transducer and activator of transcription) inhibitors that attack not only the tumor directly, but also modulate immune cells in the vicinity of the tumor to assist with tumor eradication.
Type
Private
Status
Active
Founded
2013
HQ
Cambridge, MA, US | view all locations
Website
https://www.janpixbio.com/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

2 locations detected

  • Cambridge, MA HQ

    United States

    1 Broadway

  • Mississauga, ON

    Canada

    Academic Annex, 3359 Mississauga Rd

Footer menu